A detailed history of Diversified Enterprises, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Diversified Enterprises, LLC holds 4,316 shares of ABT stock, worth $561,209. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,316
Previous 4,714 8.44%
Holding current value
$561,209
Previous $641 Million 9.83%
% of portfolio
0.04%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 10, 2025

SELL
$120.51 - $136.62 $47,962 - $54,374
-398 Reduced 8.44%
4,316 $578 Million
Q2 2025

Jul 16, 2025

SELL
$123.95 - $138.08 $23,178 - $25,820
-187 Reduced 3.82%
4,714 $641 Million
Q1 2025

May 15, 2025

BUY
$111.1 - $140.22 $95,434 - $120,448
859 Added 21.25%
4,901 $650 Million
Q4 2024

Feb 10, 2025

BUY
$111.93 - $119.39 $2,686 - $2,865
24 Added 0.6%
4,042 $457 Million
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $402,081 - $474,646
4,018 New
4,018 $458 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Diversified Enterprises, LLC Portfolio

Follow Diversified Enterprises, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified Enterprises, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Diversified Enterprises, LLC with notifications on news.